COMPANY
COMPANYHistory
- January
US FDA inspections
- July
GLP Accreditation of Alternative Study of local lymph node assay (LLNA) (the nation's first)
- May
Establishment of SCAS-BTT Bioanalysis Center (SBB) with Japan's Sumika Chemical Analysis Service
- October
GLP Accreditation of Alternative Study of Phototoxicity using in vitro 3T3 Neutral Red Uptake Assay (the nation's first)
- November
GLP inspection for OECD (Mutual Acceptance of Data) (as Korea representative)
- December
AAALAC Site Visiting and re-accreditation (US AAALAC International)
- Februauy
AAALAC full accreditation (US AAALAC International)
- October
GLP Accreditation of Safety Pharmacology (Core Battery) (the nation's first)
- November
Metabolic Analysis Center (Building C) completed
- September
Listed in KOSDAQ (stock market in South Korea)
- November
GLP Accreditation of eco-toxicity (Ministry of Environment)
- December
Completion of Test Research Building (B Building)
- January
GLP Accreditation of non-clinical testing items (Ministry of Environment)
- July
Strategic partnership agreement with Japan's CROs
- December
GLP Accreditation of non-clinical testing items (Ministry of Agriculture and Forestry)
- September
Ceremony for completion of laboratory building in Ochang
- November
Agency contract with IWASECOSFA Co., Ltd. Japan
- December
GLP Accreditation of non-clinical testing items (KFDA)
- September
Designated as eligible facility for pesticide testing (Ministry of Agriculture and Forestry)
- November
Designated as INNO-BIZ company (Small and Medium Business Administration)
- August
Established Biotoxtech (CEO Jong-Koo Kang), Capital 300 million won
- September
Registered venture business (Chungbuk Small and Medium Business Administration)